Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: mechanism for inhibition and drug resistance.

The human immunodeficiency virus type 1 (HIV-1) integrase (IN) is an essential enzyme in the life cycle of the virus and is an attractive target for the development of new drugs useful in acquired immunodeficiency syndrome multidrug therapy. Starting from the crystal structure of the 5CITEP inhibitor bound to the active site in the catalytic domain of the HIV-1 IN, two different molecular dynamics simulations in water have been carried out. In the first simulation the wild-type IN was used, whereas in the second one the double mutation T66I/M154I, described to lead to drug resistance, was introduced in the protein. Compelling differences have been observed in these two structures during analyses of the molecular dynamics trajectories, particularly in the inhibitor binding modes and in the conformational flexibility of the loop (residues 138-149) located near the three catalytic residues in the active site (Asp(64), Asp(116), Glu(152)). Because the conformational flexibility of this region is important for efficient biological activity and its behavior is quite different in the two models, we suggest a hypothetical mechanism for the inhibition and drug resistance of HIV-1 IN. These results can be useful for the rational design of more potent and selective integrase inhibitors and may allow for the design of inhibitors that will be more robust against known resistance mutations.

[1]  R. Craigie,et al.  Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Plasterk,et al.  Identification of amino acids in HIV-2 integrase involved in site-specific hydrolysis and alcoholysis of viral DNA termini. , 1993, Nucleic acids research.

[3]  J. Briggs,et al.  Investigations on human immunodeficiency virus type 1 integrase/DNA binding interactions via molecular dynamics and electrostatics calculations. , 2000, Pharmacology & therapeutics.

[4]  A. Engelman,et al.  Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. , 1994, Science.

[5]  F. Bushman,et al.  Crystal structure of an active two-domain derivative of Rous sarcoma virus integrase. , 2000, Journal of molecular biology.

[6]  The catalytic domain of human immunodeficiency virus integrase: ordered active site in the F185H mutant , 1996, FEBS letters.

[7]  A M Gronenborn,et al.  Solution structure of the DNA binding domain of HIV-1 integrase. , 1995, Biochemistry.

[8]  T. Steitz,et al.  Structural basis for the 3′‐5′ exonuclease activity of Escherichia coli DNA polymerase I: a two metal ion mechanism. , 1991, The EMBO journal.

[9]  A. Engelman,et al.  Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro , 1992, Journal of virology.

[10]  Robert J. Harrison,et al.  High-Performance Computational Chemistry: Hartree-Fock Electronic Structure Calculations on Massively Parallel Processors , 1999, Int. J. High Perform. Comput. Appl..

[11]  A. Gronenborn,et al.  Solution structure of the His 12 → Cys mutant of the N‐terminal zinc binding domain of HIV‐1 integrase complexed to cadmium , 1998, Protein science : a publication of the Protein Society.

[12]  J A McCammon,et al.  Brownian and essential dynamics studies of the HIV-1 integrase catalytic domain. , 1998, Journal of biomolecular structure & dynamics.

[13]  V. Mikol,et al.  Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: high level of similarity of the active site with other viral integrases. , 1998, Journal of molecular biology.

[14]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[15]  M. Bukrinsky,et al.  Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Thornton,et al.  Satisfying hydrogen bonding potential in proteins. , 1994, Journal of molecular biology.

[17]  R. Plasterk,et al.  Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type I integrase protein. , 1993, Nucleic acids research.

[18]  H. Berendsen,et al.  Essential dynamics of proteins , 1993, Proteins.

[19]  J. Andrew McCammon,et al.  HIV-1 Integrase Inhibitor Interactions at the Active Site: Prediction of Binding Modes Unaffected by Crystal Packing , 2000 .

[20]  P. Brown,et al.  A nucleoprotein complex mediates the integration of retroviral DNA. , 1989, Genes & development.

[21]  J A McCammon,et al.  Ordered water and ligand mobility in the HIV-1 integrase-5CITEP complex: a molecular dynamics study. , 2001, Journal of medicinal chemistry.

[22]  Ruben Abagyan,et al.  ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation , 1994, J. Comput. Chem..

[23]  A Wlodawer,et al.  Binding of Different Divalent Cations to the Active Site of Avian Sarcoma Virus Integrase and Their Effects on Enzymatic Activity* , 1997, The Journal of Biological Chemistry.

[24]  T. Straatsma,et al.  THE MISSING TERM IN EFFECTIVE PAIR POTENTIALS , 1987 .

[25]  P. Brown,et al.  Photo-cross-linking studies suggest a model for the architecture of an active human immunodeficiency virus type 1 integrase-DNA complex. , 1998, Biochemistry.

[26]  J A Grobler,et al.  Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. , 2000, Science.

[27]  E. Asante-Appiah,et al.  HIV-1 integrase: structural organization, conformational changes, and catalysis. , 1999, Advances in virus research.

[28]  D. Esposito,et al.  Sequence specificity of viral end DNA binding by HIV‐1 integrase reveals critical regions for protein–DNA interaction , 1998, The EMBO journal.

[29]  F. Bushman,et al.  Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Robert Craigie,et al.  HIV-1 DNA integration: Mechanism of viral DNA cleavage and DNA strand transfer , 1991, Cell.

[31]  M S Lewis,et al.  Zn2+ promotes the self-association of human immunodeficiency virus type-1 integrase in vitro. , 1997, Biochemistry.

[32]  G Vriend,et al.  WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.

[33]  D. Hazuda,et al.  X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293)--an initial glance of the viral DNA binding platform. , 2000, Journal of molecular biology.

[34]  Rolf Boelens,et al.  The DNA-binding domain of HIV-1 integrase has an SH3-like fold , 1995, Nature Structural Biology.

[35]  E. De Clercq Novel compounds in preclinical/early clinical development for the treatment of HIV infections , 2000, Reviews in medical virology.

[36]  F. Bushman,et al.  The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity. , 1999, Biochemistry.

[37]  A. Engelman,et al.  The core and carboxyl-terminal domains of the integrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding , 1994, Journal of virology.

[38]  M. Chandler,et al.  Bacterial transposases and retroviral integrases , 1995, Molecular microbiology.

[39]  F. Bushman,et al.  Developing a dynamic pharmacophore model for HIV-1 integrase. , 2000, Journal of medicinal chemistry.

[40]  D. Davies,et al.  Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .

[42]  A. Engelman,et al.  Critical contacts between HIV‐1 integrase and viral DNA identified by structure‐based analysis and photo‐crosslinking , 1997, The EMBO journal.

[43]  P. Brown,et al.  Mapping features of HIV-1 integrase near selected sites on viral and target DNA molecules in an active enzyme-DNA complex by photo-cross-linking. , 1997, Biochemistry.

[44]  A. Wlodawer Crystal structures of catalytic core domains of retroviral integrases and role of divalent cations in enzymatic activity. , 1999, Advances in virus research.

[45]  G. Cohen,et al.  Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[46]  A. Gronenborn,et al.  Solution structure of the N-terminal zinc binding domain of HIV-1 integrase , 1997, Nature Structural Biology.

[47]  S. Lowen The Biophysical Journal , 1960, Nature.

[48]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .

[49]  F. Bushman,et al.  Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain. , 2001, Acta crystallographica. Section D, Biological crystallography.

[50]  J A McCammon,et al.  Molecular dynamics studies on the HIV-1 integrase catalytic domain. , 1999, Biophysical journal.

[51]  M. Billeter,et al.  MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.

[52]  A. Skalka,et al.  Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases , 1992, Molecular and cellular biology.

[53]  L. R. Scott,et al.  Electrostatics and diffusion of molecules in solution: simulations with the University of Houston Brownian dynamics program , 1995 .

[54]  P. Brown,et al.  Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. , 1992, Science.

[55]  R. Plasterk,et al.  Refined solution structure of the c‐terminal DNA‐binding domain of human immunovirus‐1 integrase , 1999, Proteins.

[56]  T. Masuda,et al.  Identification of Critical Amino Acid Residues in Human Immunodeficiency Virus Type 1 IN Required for Efficient Proviral DNA Formation at Steps prior to Integration in Dividing and Nondividing Cells , 2000, Journal of virology.

[57]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .